Published in Vaccine Weekly, May 17th, 2006
According to recent research from France, "The study examined the effects of various progesterone and mifepristone concentrations on the proliferation and apoptosis of the human ovarian cancer cell line, OVCAR-3. OVCAR-3 cells were incubated with progesterone and mifepristone at concentrations ranging from 10-3 to 10-9 M."
"Proliferation and apoptosis were studied by means of inverted optical microscopy, DAPI staining, and crystal violet assay," explained R. Fauvet and colleagues, Hopital Tenon. "Immunoblotting was used to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-05-17)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.